LumiraDx Partners with British In Vitro Diagnostics Association
Link up will involve reporting on role of rapid diagnostics in taking on antimicrobial resistance
Read More
Author: John Pinching
MSD’s pembrolizumab therapy gets NICE approval
1,500 people set to receive new skin cancer treatment that reduces the risk of it returning
Read More
Novo Nordisk’s icodec therapy delivers positive data
Data shows participants achieved greater treatment satisfaction when switching to icodec
Read More
AlzeCure releases results from TrkA-NAM data
Company presents new pain data on the anti-inflammatory effects of its TrkA-NAM
Read More
Genetically modified herpes combats advanced cancers
A new genetically engineered virus has delivered a one-two punch in initial phase 1 trial
Read More- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
